NBI-1117567

N/A

Report date: 2026/03/20 15:39:59
NME

Base Information

Drug NameNBI-1117567
Drug Alias NameNBI-1117567NBI-'567NBI-567
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M1 agonists
TargetsMuscarinic acetylcholine receptor M1
Therapy Area/IndicationsMental DisordersAlzheimer DiseaseCentral Nervous System Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNxera Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeurocrine Biosciences IncNxera Pharma Co Ltd
Inactive CompaniesN/A
Active IndicationsMental DisordersAlzheimer DiseaseCentral Nervous System Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A